Advances in researches on the onset and duration of the action of sildenafil.
- Author:
Huai-Peng WANG
1
;
Xiao-Yong PU
Author Information
1. Department of Urology, Guangdong Provincial People's Hospital, Guangzhou, Guangdong 510080, China. andrology@126.com
- Publication Type:Journal Article
- MeSH:
Animals;
Erectile Dysfunction;
drug therapy;
metabolism;
Female;
Humans;
Male;
Phosphodiesterase Inhibitors;
pharmacokinetics;
therapeutic use;
Piperazines;
pharmacokinetics;
therapeutic use;
Purines;
pharmacokinetics;
therapeutic use;
Rats;
Sildenafil Citrate;
Sulfones;
pharmacokinetics;
therapeutic use
- From:
National Journal of Andrology
2005;11(5):392-395
- CountryChina
- Language:Chinese
-
Abstract:
Sildenafil is an orally effective therapy for the treatment of men with erectile dysfunction (ED). It is a specific and selective inhibitor of phosphodiesterase type 5 (PDE5). This paper reviews the researches on the pharmacokinetics, the onset and duration of the action of Sildenafil.
